SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Hormone Lowers Glucose Levels in Mice, INSERM Study
November 5, 2008
 · 
1 min read
Drug Development
Blocking Enzyme May Help Childhood Leukemia, Children’s Hospital Boston And Dana-Farber Cancer Institute Study
November 4, 2008
 · 
1 min read
Drug Development
Sarcospan, A Little Protein For A Big Problem, Rockefeller University Study
November 3, 2008
 · 
1 min read
Drug Development
University of California, Irvine Scientists Find Way To Treat Fragile X In Mice
November 3, 2008
 · 
1 min read
Drug Development
Transplantation: ‘Molecular Miscegenation’ Blurs The Boundary Between Self And Non-Self, King’s College London Study
October 31, 2008
 · 
1 min read
Drug Development
Rare Cancer Requires Support From Immune System To Develop, University of Texas Southwestern Medical Center Study
October 31, 2008
 · 
1 min read
Drug Development
Hurdles For Muscular Dystrophy Therapy Cleared, University of Missouri Development
October 30, 2008
 · 
1 min read
Drug Development
Study Shows Potential Advance In Fighting E Coli, Japanese and Canadian Scientists Report in the Proceedings of the National Academy of Sciences
October 28, 2008
 · 
1 min read
Drug Development
Bilberry Extract May Ease The Damages Of Stress, Chinese And Singaporean Researchers Say
October 28, 2008
 · 
1 min read
Drug Development
Fight Obesity With New Antibody That Degrades Appetite Stimulant? The Scripps Research Institute Scientists Discover New Antibody
October 28, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Virpax® Successfully Completes Preclinical Dermal Safety Studies for Epoladerm™
January 18, 2022
 · 
3 min read
Drug Development
Praxis Precision Medicines Announces Publication of Preclinical Data Highlighting Differentiated and Potent Antiepileptic Activity of PRAX-562
January 18, 2022
 · 
6 min read
Drug Development
LAVA Therapeutics Presents Preclinical Data on its Gammabody™ T Cell Engager Platform at the 21st Annual PepTalk Conference
January 18, 2022
 · 
6 min read
Drug Development
InnoCare and Keymed Jointly Announce Dosing of First Patient in Clinical Trial of CD20xCD3 Bispecific Antibody CM355
January 18, 2022
 · 
3 min read
Drug Development
EDAP Announces Publication of Positive Pre-clinical Results Using Intraoperative HIFU Ablation of the Pancreas in the Journal Cancers
January 13, 2022
 · 
4 min read
Drug Development
Prior to Phase III Psoriasis Data Release Can Fite Reports that Piclidenoson Destroys Pathological Skin Cells in vitro
January 13, 2022
 · 
6 min read
Drug Development
Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110
January 12, 2022
 · 
5 min read
Drug Development
HEARTPOINT GLOBAL ANNOUNCES SUCCESSFUL PRE-CLINICAL TRIAL OF NEW IMPLANT SYSTEM
January 11, 2022
 · 
4 min read
Drug Development
Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK2735, Company’s Lead Dual GLP-1/GIP Receptor Agonist
January 10, 2022
 · 
6 min read
Drug Development
Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts
January 10, 2022
 · 
12 min read
Drug Development
Immuneering Reports Compelling Preclinical Data on IMM-1-104 in NRAS Mutant Melanoma Model And Will Host Key External Expert Investor Event
January 6, 2022
 · 
8 min read
Drug Development
Vetigenics Announces Publication Of Comprehensive Preclinical Data For Anti-Canine CTLA4 Monoclonal Antibody
January 5, 2022
 · 
4 min read
Drug Development
Lixte Biotechnology’s LB-100 Reported to Convert Immunologically Unresponsive (“Cold”) Tumors to Immunologically Responsive (“Hot”) Tumors
January 5, 2022
 · 
4 min read
Drug Development
Cystic Fibrosis Foundation Announces Investment in SalioGen Therapeutics to Fund Genetic Therapies Research
January 5, 2022
 · 
4 min read
Drug Development
Clover Biopharmaceuticals Announces Construction of a New R&D Center in Zhangjiang Hi-Tech Park in Pudong Shanghai
January 4, 2022
 · 
3 min read
FDA
Adverum Biotechnologies Granted Orphan Drug Designation by FDA for Gene Therapy Candidate in Preclinical Development for the Treatment of Blue Cone Monochromacy
January 4, 2022
 · 
3 min read
Drug Development
Prometheus Biosciences and Dr. Falk Pharma Advance PR600 and Trigger Final Preclinical Milestone PaymentInvestigational New Drug Application for PR600 expected in 3Q 2022
January 3, 2022
 · 
6 min read
Drug Development
Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron Immune Evasion and Receptor Engagement
December 31, 2021
 · 
14 min read
Drug Development
Rational Vaccines’ RVX1001 Vaccine Candidate Protects Against HSV Ocular Infection in vivo
December 28, 2021
 · 
5 min read
Drug Development
Cyrus Biotechnology’s COVID therapeutic lead, ACE2.v2.4, strongly binds and neutralizes SARS-CoV-2 omicron variant potentially providing long term protection
December 27, 2021
 · 
5 min read
Load More